Ipilimumab/nivolumabHepatotoxicity: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1799卷 / 1期

关键词：

D O I：

10.1007/s40278-020-77234-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：232 / 232

相关论文

共 50 条

[1] Ipilimumab/NivolumabHepatotoxicity: case report
Reactions Weekly, 2024, 2038 (1) : 168 - 168
[2] Bevacizumab and ipilimumab/nivolumabHepatotoxicity: case report
Reactions Weekly, 2018, 1687 (1) : 50 - 50
[3] Ipilimumab/nivolumabHepatotoxicity and prominent systemic vitiligo: case report
Reactions Weekly, 2017, 1642 (1) : 170 - 170
[4] Ipilimumab/nivolumabHepatotoxicity in the form of cholestatic liver injury: case report
Reactions Weekly, 2021, 1878 (1) : 283 - 283
[5] NivolumabHepatotoxicity: case report
Reactions Weekly, 2017, 1650 (1) : 212 - 212
[6] NivolumabHepatotoxicity: case report
Reactions Weekly, 2017, 1658 (1) : 352 - 352
[7] NivolumabHepatotoxicity: case report
Reactions Weekly, 2022, 1894 (1) : 257 - 257
[8] NivolumabHepatotoxicity: case report
Reactions Weekly, 2019, 1750 (1) : 202 - 202
[9] NivolumabHepatotoxicity: case report
Reactions Weekly, 2016, 1630 (1) : 184 - 184
[10] NivolumabHepatotoxicity: case report
Reactions Weekly, 2017, 1658 (1) : 351 - 351

← 1 2 3 4 5 →